Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 31,950
-500 (-1.54%)
At close: Sep 5, 2025
-1.54% (1Y)
| Market Cap | 1.72T |
| Revenue (ttm) | 150.09B |
| Net Income (ttm) | 2.23B |
| Shares Out | 50.75M |
| EPS (ttm) | 44.81 |
| PE Ratio | 770.43 |
| Forward PE | 296.83 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 534,974 |
| Average Volume | 368,623 |
| Open | 32,100 |
| Previous Close | 32,450 |
| Day's Range | 30,950 - 32,150 |
| 52-Week Range | 24,000 - 52,000 |
| Beta | 0.80 |
| RSI | 65.05 |
| Earnings Date | Aug 14, 2025 |